Queensland COVID-19 research

  • Use of convalescent plasma in clinical trials for the prevention and treatment of COVID-19

    June 2020

    Australian research into the use of convalescent plasma in clinical trials for the prevention and treatment of COVID-19 should be supported according to a leading immunologist from Griffith University’s Institute for Glycomics. Professor Michael Good AO, a member of the National COVID-19 Health and Research Advisory Committee and chair of the working group on convalescent plasma therapy, said the working group’s conclusions included the active support of research into trials of convalescent plasma for treatment and prophylaxis. “Convalescent plasma therapy involves the transfusion of blood plasma collected from patients recovered from COVID-19. As they will have produced antibodies against the disease, the aim is to provide passive immunity in infected patients, as opposed to active immunity in patients that would be induced by a vaccine.” Said Professor Good. Convalescent plasma is not a new therapy and has been used and trialled in influenza, SARS-CoV-1 and Ebola infection, as well as in many established diseases such as diphtheria and tetanus.

Artists in Residence Science Program

Art meets science exhibition

  • About the exhibition

    The 2012–2018 Art meets Science Exhibitions provided an opportunity for artists from across South East Queensland to join the artists participating in the Artist in Residence Science program in showcasing their recent artworks that demonstrate a strong art-science connection. Find out more about the artists and artworks featured in these exhibitions in the 2015-2018 Art meets Science exhibition catalogues.

    Therese Flynn-Clarke - Moths of the Caldera - Opodiphthera eucalypti (Gum Emperor Moth) - made from all natural plant fibres